BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kinnman N, Lindblad A, Housset C, Buentke E, Scheynius A, Strandvik B, Hultcrantz R. Expression of cystic fibrosis transmembrane conductance regulator in liver tissue from patients with cystic fibrosis. Hepatology 2000;32:334-40. [PMID: 10915740 DOI: 10.1053/jhep.2000.9111] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Lewindon PJ, Shepherd RW, Walsh MJ, Greer RM, Williamson R, Pereira TN, Frawley K, Bell SC, Smith JL, Ramm GA. Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsy. Hepatology 2011;53:193-201. [DOI: 10.1002/hep.24014] [Cited by in Crossref: 68] [Cited by in F6Publishing: 57] [Article Influence: 5.7] [Reference Citation Analysis]
2 Scholte BJ, Davidson DJ, Wilke M, de Jonge HR. Animal models of cystic fibrosis. Journal of Cystic Fibrosis 2004;3:183-90. [DOI: 10.1016/j.jcf.2004.05.039] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 3.3] [Reference Citation Analysis]
3 Henrion-Caude A, Flamant C, Roussey M, Housset C, Flahault A, Fryer AA, Chadelat K, Strange RC, Clement A. Liver disease in pediatric patients with cystic fibrosis is associated with glutathione S-transferase P1 polymorphism. Hepatology 2002;36:913-7. [PMID: 12297838 DOI: 10.1053/jhep.2002.35534] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 2.2] [Reference Citation Analysis]
4 Quaglia A, Roberts EA, Torbenson M. Developmental and Inherited Liver Disease. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 111-274. [DOI: 10.1016/b978-0-7020-6697-9.00003-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Colombo C, Russo MC, Zazzeron L, Romano G. Liver disease in cystic fibrosis. J Pediatr Gastroenterol Nutr 2006;43 Suppl 1:S49-55. [PMID: 16819402 DOI: 10.1097/01.mpg.0000226390.02355.52] [Cited by in Crossref: 67] [Cited by in F6Publishing: 45] [Article Influence: 4.5] [Reference Citation Analysis]
6 Gu X, Manautou JE. Regulation of hepatic ABCC transporters by xenobiotics and in disease states. Drug Metab Rev 2010;42:482-538. [PMID: 20233023 DOI: 10.3109/03602531003654915] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 3.7] [Reference Citation Analysis]
7 Fiorotto R, Amenduni M, Mariotti V, Fabris L, Spirli C, Strazzabosco M. Src kinase inhibition reduces inflammatory and cytoskeletal changes in ΔF508 human cholangiocytes and improves cystic fibrosis transmembrane conductance regulator correctors efficacy. Hepatology 2018;67:972-88. [PMID: 28836688 DOI: 10.1002/hep.29400] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
8 Häusler M, Heimann G, Biesterfeld S. Fibrosis: a general feature in cystic fibrosis? J Pediatr Gastroenterol Nutr 2002;34:236-9. [PMID: 11840048 DOI: 10.1097/00005176-200202000-00026] [Reference Citation Analysis]
9 Fabris L, Fiorotto R, Spirli C, Cadamuro M, Mariotti V, Perugorria MJ, Banales JM, Strazzabosco M. Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases. Nat Rev Gastroenterol Hepatol 2019;16:497-511. [PMID: 31165788 DOI: 10.1038/s41575-019-0156-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
10 Trauner M, Boyer JL. Cholestatic syndromes: . Current Opinion in Gastroenterology 2001;17:242-56. [DOI: 10.1097/00001574-200105000-00007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
11 Drzymała-czyż S, Szczepanik M, Krzyżanowska P, Duś-żuchowska M, Pogorzelski A, Sapiejka E, Juszczak P, Lisowska A, Koletzko B, Walkowiak J. Serum Phospholipid Fatty Acid Composition in Cystic Fibrosis Patients with and without Liver Cirrhosis. Ann Nutr Metab 2017;71:91-8. [DOI: 10.1159/000477913] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
12 Glaser S, Francis H, DeMorrow S, LeSage G, Fava G, Marzioni M, Venter J, Alpini G. Heterogeneity of the intrahepatic biliary epithelium. World J Gastroenterol 2006; 12(22): 3523-3536 [PMID: 16773709 DOI: 10.3748/wjg.v12.i22.3523] [Cited by in CrossRef: 58] [Cited by in F6Publishing: 50] [Article Influence: 3.6] [Reference Citation Analysis]
13 Wlcek K, Stieger B. ATP-binding cassette transporters in liver: Hepatic ABC Transporters. BioFactors 2014;40:188-98. [DOI: 10.1002/biof.1136] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
14 Zsembery A, Jessner W, Sitter G, Spirlí C, Strazzabosco M, Graf J. Correction of CFTR malfunction and stimulation of Ca-activated Cl channels restore HCO3- secretion in cystic fibrosis bile ductular cells. Hepatology. 2002;35:95-104. [PMID: 11786964 DOI: 10.1053/jhep.2002.30423] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 2.1] [Reference Citation Analysis]
15 Rodrigues CM, Steer CJ. The therapeutic effects of ursodeoxycholic acid as an anti-apoptotic agent. Expert Opinion on Investigational Drugs 2005;10:1243-53. [DOI: 10.1517/13543784.10.7.1243] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 2.6] [Reference Citation Analysis]
16 Verhaeghe C, Delbecque K, de Leval L, Oury C, Bours V. Early inflammation in the airways of a cystic fibrosis foetus. Journal of Cystic Fibrosis 2007;6:304-8. [DOI: 10.1016/j.jcf.2006.12.001] [Cited by in Crossref: 69] [Cited by in F6Publishing: 61] [Article Influence: 4.6] [Reference Citation Analysis]
17 Bartlett JR, Friedman KJ, Ling SC, Pace RG, Bell SC, Bourke B, Castaldo G, Castellani C, Cipolli M, Colombo C, Colombo JL, Debray D, Fernandez A, Lacaille F, Macek M Jr, Rowland M, Salvatore F, Taylor CJ, Wainwright C, Wilschanski M, Zemková D, Hannah WB, Phillips MJ, Corey M, Zielenski J, Dorfman R, Wang Y, Zou F, Silverman LM, Drumm ML, Wright FA, Lange EM, Durie PR, Knowles MR; Gene Modifier Study Group. Genetic modifiers of liver disease in cystic fibrosis. JAMA 2009;302:1076-83. [PMID: 19738092 DOI: 10.1001/jama.2009.1295] [Cited by in Crossref: 189] [Cited by in F6Publishing: 149] [Article Influence: 14.5] [Reference Citation Analysis]
18 Ferenci P, Zollner G, Trauner M. Hepatic transport systems: Hepatic transport systems. Journal of Gastroenterology and Hepatology 2002;17:S105-12. [DOI: 10.1046/j.1440-1746.17.s1.15.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
19 Lewindon PJ, Pereira TN, Hoskins AC, Bridle KR, Williamson RM, Shepherd RW, Ramm GA. The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease. Am J Pathol. 2002;160:1705-1715. [PMID: 12000722 DOI: 10.1016/s0002-9440(10)61117-0] [Cited by in Crossref: 91] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
20 Staufer K. Current Treatment Options for Cystic Fibrosis-Related Liver Disease. Int J Mol Sci 2020;21:E8586. [PMID: 33202578 DOI: 10.3390/ijms21228586] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
21 Kroll T, Prescher M, Smits SHJ, Schmitt L. Structure and Function of Hepatobiliary ATP Binding Cassette Transporters. Chem Rev 2021;121:5240-88. [PMID: 33201677 DOI: 10.1021/acs.chemrev.0c00659] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
22 Collardeau-Frachon S, Bouvier R, Le Gall C, Rivet C, Cabet F, Bellon G, Lachaux A, Scoazec JY. Unexpected diagnosis of cystic fibrosis at liver biopsy: a report of four pediatric cases. Virchows Arch 2007;451:57-64. [PMID: 17554556 DOI: 10.1007/s00428-007-0434-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
23 Kim JS, Jin Y, Lemasters JJ. Reactive oxygen species, but not Ca2+ overloading, trigger pH- and mitochondrial permeability transition-dependent death of adult rat myocytes after ischemia-reperfusion. Am J Physiol Heart Circ Physiol 2006;290:H2024-34. [PMID: 16399872 DOI: 10.1152/ajpheart.00683.2005] [Cited by in Crossref: 207] [Cited by in F6Publishing: 193] [Article Influence: 12.9] [Reference Citation Analysis]
24 Pereira TN, Lewindon PJ, Greer RM, Hoskins AC, Williamson RM, Shepherd RW, Ramm GA. Transcriptional basis for hepatic fibrosis in cystic fibrosis-associated liver disease. J Pediatr Gastroenterol Nutr 2012;54:328-35. [PMID: 22157922 DOI: 10.1097/MPG.0b013e3182432034] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
25 McKeon D, Day A, Parmar J, Alexander G, Bilton D. Hepatocellular carcinoma in association with cirrhosis in a patient with cystic fibrosis.J Cyst Fibros. 2004;3:193-195. [PMID: 15463908 DOI: 10.1016/j.jcf.2004.04.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
26 Kaminski N, Belperio JA, Bitterman PB, Chen L, Chensue SW, Choi AM, Dacic S, Dauber JH, du Bois RM, Enghild JJ, Fattman CL, Grutters JC, Haegens A, Hanford LE, Heintz N, Henson PM, Hogaboam C, Kagan VE, Keane MP, Kunkel SL, Land S, Loyd JE, Lukacs N, Macpherson M, Manning B, Manning N, Martinelli M, Moller DR, Morse D, Mossman B, Noble PW, Nowak N, Oury TD, Pardo A, Perez A, Petty TL, Phan SH, Ramos-nino ME, Ray P, Rogers RM, Sato H, Scapoli L, Schaefer LM, Selman M, Stern M, Strollo DC, Tyurin VA, Valnickova Z, Welsh KI, Witzmann FA, Yousem SA, Strieter RM. Idiopathic Pulmonary Fibrosis. Am J Respir Cell Mol Biol 2003;29:S1-S105. [DOI: 10.1165/rcmb.2003-0159su] [Cited by in Crossref: 27] [Article Influence: 1.4] [Reference Citation Analysis]
27 Javitt NB. History of hepatic bile formation: old problems, new approaches. Adv Physiol Educ 2014;38:279-85. [PMID: 25434010 DOI: 10.1152/advan.00076.2014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
28 Fiorotto R, Amenduni M, Mariotti V, Cadamuro M, Fabris L, Spirli C, Strazzabosco M. Animal models for cystic fibrosis liver disease (CFLD). Biochim Biophys Acta Mol Basis Dis 2019;1865:965-9. [PMID: 30071276 DOI: 10.1016/j.bbadis.2018.07.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
29 Colombo C, Battezzati PM. Liver involvement in cystic fibrosis: primary organ damage or innocent bystander? J Hepatol 2004;41:1041-4. [PMID: 15582140 DOI: 10.1016/j.jhep.2004.10.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
30 Parisi GF, Di Dio G, Franzonello C, Gennaro A, Rotolo N, Lionetti E, Leonardi S. Liver disease in cystic fibrosis: an update. Hepat Mon. 2013;13:e11215. [PMID: 24171010 DOI: 10.5812/hepatmon.11215] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
31 Perdue DG, Cass OW, Milla C, Dunitz J, Jessurun J, Sharp HL, Schwarzenberg SJ. Hepatolithiasis and cholangiocarcinoma in cystic fibrosis: a case series and review of the literature.Dig Dis Sci. 2007;52:2638-2642. [PMID: 17443409 DOI: 10.1007/s10620-006-9259-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
32 Conese M, Beccia E, Castellani S, Di Gioia S, Colombo C, Angiolillo A, Carbone A. The long and winding road: stem cells for cystic fibrosis. Expert Opin Biol Ther 2018;18:281-92. [PMID: 29216777 DOI: 10.1080/14712598.2018.1413087] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
33 Mrugacz M, Zak J, Bakunowicz-lazarczyk A, Wysocka J, Kaczmarski M. ICAM-1 expression on conjunctival epithelial cells in patients with cystic fibrosis. Cytometry 2007;72B:204-8. [DOI: 10.1002/cyto.b.20159] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
34 Cottart CH, Bonvin E, Rey C, Wendum D, Bernaudin JF, Dumont S, Lasnier E, Debray D, Clément A, Housset C, Bonora M. Impact of nutrition on phenotype in CFTR-deficient mice. Pediatr Res 2007;62:528-32. [PMID: 17805210 DOI: 10.1203/PDR.0b013e318155a61d] [Cited by in Crossref: 22] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
35 Mailhot G. Vitamin D bioavailability in cystic fibrosis: a cause for concern? Nutr Rev. 2012;70:280-293. [PMID: 22537214 DOI: 10.1111/j.1753-4887.2012.00471.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
36 Scott J, Jones AM, Piper Hanley K, Athwal VS. Review article: epidemiology, pathogenesis and management of liver disease in adults with cystic fibrosis. Aliment Pharmacol Ther 2022. [PMID: 35048397 DOI: 10.1111/apt.16749] [Reference Citation Analysis]
37 Bettinardi N, Felicetta I, Tomasi PA, Colombo C. Carbohydrate 19-9 antigen is not a marker of liver disease in patients with cystic fibrosis.Clin Chem Lab Med. 2003;41:311-316. [PMID: 12705340 DOI: 10.1515/CCLM.2003.050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
38 Colombo C, Battezzati PM, Crosignani A, Morabito A, Costantini D, Padoan R, Giunta A. Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome. Hepatology. 2002;36:1374-1382. [PMID: 12447862 DOI: 10.1002/hep.1840360613] [Cited by in Crossref: 149] [Cited by in F6Publishing: 79] [Article Influence: 7.8] [Reference Citation Analysis]
39 Lemaitre C, Dominique S, Billoud E, Eliezer M, Montialoux H, Quillard M, Riachi G, Koning E, Morisse-Pradier H, Savoye G. Relevance of 3D Cholangiography and Transient Elastography to Assess Cystic Fibrosis-Associated Liver Disease? Can Respir J. 2016;2016:4592702. [PMID: 27445541 DOI: 10.1155/2016/4592702] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
40 Sharma M, Benharouga M, Hu W, Lukacs GL. Conformational and Temperature-sensitive Stability Defects of the ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator in Post-endoplasmic Reticulum Compartments. Journal of Biological Chemistry 2001;276:8942-50. [DOI: 10.1074/jbc.m009172200] [Cited by in Crossref: 158] [Cited by in F6Publishing: 94] [Article Influence: 7.5] [Reference Citation Analysis]